175 related articles for article (PubMed ID: 16823179)
21. Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors.
Boström P; Söderström M; Palokangas T; Vahlberg T; Collan Y; Carpen O; Hirsimäki P
BMC Res Notes; 2009 Jul; 2():140. PubMed ID: 19615042
[TBL] [Abstract][Full Text] [Related]
22. Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas.
Dobashi Y; Jiang SX; Shoji M; Morinaga S; Kameya T
J Pathol; 2003 Feb; 199(2):208-20. PubMed ID: 12533834
[TBL] [Abstract][Full Text] [Related]
23. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
Luhtala S; Staff S; Tanner M; Isola J
Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy.
Pelosio P; Barbareschi M; Bonoldi E; Marchetti A; Verderio P; Caffo O; Bevilacqua P; Boracchi P; Buttitta F; Barbazza R; Dalla Palma P; Gasparini G
Ann Oncol; 1996 Sep; 7(7):695-703. PubMed ID: 8905027
[TBL] [Abstract][Full Text] [Related]
25. Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer.
Montanaro L; Vici M; Donati G; Ceccarelli C; Santini D; Treré D; Derenzini M
Histol Histopathol; 2007 Jul; 22(7):769-75. PubMed ID: 17455150
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
[TBL] [Abstract][Full Text] [Related]
27. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
van Diest PJ; Michalides RJ; Jannink L; van der Valk P; Peterse HL; de Jong JS; Meijer CJ; Baak JP
Am J Pathol; 1997 Feb; 150(2):705-11. PubMed ID: 9033283
[TBL] [Abstract][Full Text] [Related]
29. E- and A-type cyclins as markers for cancer diagnosis and prognosis.
Yasmeen A; Berdel WE; Serve H; Müller-Tidow C
Expert Rev Mol Diagn; 2003 Sep; 3(5):617-33. PubMed ID: 14510182
[TBL] [Abstract][Full Text] [Related]
30. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
[TBL] [Abstract][Full Text] [Related]
31. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Jankowska R
Pol Merkur Lekarski; 2011 Apr; 30(178):253-8. PubMed ID: 21595169
[TBL] [Abstract][Full Text] [Related]
32. CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.
Elsheikh S; Green AR; Aleskandarany MA; Grainge M; Paish CE; Lambros MB; Reis-Filho JS; Ellis IO
Breast Cancer Res Treat; 2008 May; 109(2):325-35. PubMed ID: 17653856
[TBL] [Abstract][Full Text] [Related]
33. Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas.
Collecchi P; Santoni T; Gnesi E; Giuseppe Naccarato A; Passoni A; Rocchetta M; Danesi R; Bevilacqua G
Cytometry; 2000 Aug; 42(4):254-60. PubMed ID: 10934345
[TBL] [Abstract][Full Text] [Related]
34. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
35. p53 mutations in benign breast tissue.
Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ
J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.
Reis-Filho JS; Savage K; Lambros MB; James M; Steele D; Jones RL; Dowsett M
Mod Pathol; 2006 Jul; 19(7):999-1009. PubMed ID: 16648863
[TBL] [Abstract][Full Text] [Related]
37. Expression of cyclin genes in human gastric cancer and in first degree relatives.
Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E
Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
[TBL] [Abstract][Full Text] [Related]
39. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer.
Overgaard J; Yilmaz M; Guldberg P; Hansen LL; Alsner J
Acta Oncol; 2000; 39(3):327-33. PubMed ID: 10987229
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of cyclin E expression in breast cancer: a meta-analysis.
Gao S; Ma JJ; Lu C
Tumour Biol; 2013 Dec; 34(6):3423-30. PubMed ID: 23775012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
